美国整形外科医生乳房植入物影像监测:美国食品药品监督管理局建议与临床现实
该研究通过在线调查美国整形外科医师学会活跃会员,评估乳房植入物破裂影像监测的临床实践。结果显示仅37.7%的受访者按推荐间隔推荐MRI,55%仅在植入物出现问题时进行影像检查;学术型、低手术量及经验较少的医生更倾向于推荐MRI。作者认为筛查建议需基于证据并与常见实践一致,以避免过度的系统、提供者和患者负担。
要点
- 仅37.7%的受访整形外科医生按FDA推荐的间隔(植入后3年及之后每2年)推荐MRI监测。
- 55%的受访者仅在植入物出现问题时才进行影像检查。
- 学术型医生、低手术量医生及从业少于5年的医生更倾向于推荐MRI监测。
诊断标准与关键数值
- 美国食品药品监督管理局建议植入后3年进行磁共振成像监测,之后每2年一次。
- 37.7%的受访者按推荐间隔推荐MRI。
- 55%的受访者仅在植入物出现问题时进行影像检查。
- 学术型医生更频繁推荐MRI(56.3% vs 39.3%,p=0.0002)。
- 从业少于5年的医生比从业超过25年的医生推荐MRI的可能性高四倍(60.8% vs 28.1%,p<0.0001)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- MRI的局限性包括高成本、时间投入和設備限制。
- 调查回应率为16.5%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Device rupture is considered a major complication associated with breast implants. The U.S. Food and Drug Administration recommends magnetic resonance imaging (MRI) surveillance 3 years after implantation and then every 2 years, but adherence to these recommendations is poor. The authors identified current practice management for breast implant rupture surveillance by surveying practicing U.S. plastic surgeons.
METHODS: An online survey of all active members of the American Society of Plastic Surgeons was performed. Questions analyzed imaging practice patterns related to breast implants. Logistic regression models were used to analyze determinants for radiographic imaging in breast implant patients.
RESULTS: The survey had a response rate of 16.5 percent. For patients with breast implants, 37.7 percent of respondents recommended MRI at the recommended intervals. Fifty-five percent perform imaging only if there is a problem with the implant. Academic surgeons more frequently recommended MRI (56.3 percent and 39.3 percent; p = 0.0002). Surgeons with less than 5 years of experience are four times more likely to order MRI than surgeons with over 25 years' experience (60.8 percent and 28.1 percent; p < 0.0001). Furthermore, lower volume surgeons recommend significantly more MRI (45.2 percent and 27.3 percent; p = 0.001). Respondents are almost two times more likely to recommend MRI in reconstructive versus cosmetic patients (51.2 percent and 35.6 percent; p = 0.0004).
CONCLUSIONS: MRI limitations include high costs, time commitments, and equipment constraints. Fewer than 40 percent of survey respondents suggest the recommended screening frequency to their patients; however, academic, low-volume, early-career surgeons are more likely to recommend MRI implant monitoring. Screening recommendations need to be evidence based and align with common practices to prevent undue system, provider, and patient burden.
引用
- Carr LW, Roberts J, Mericli AF, et al. Breast Implant Imaging Surveillance among U.S. Plastic Surgeons: U.S. Food and Drug Administration Recommendations versus Clinical Reality. Plast Reconstr Surg. 2020. PMID: 32459768. doi:10.1097/PRS.0000000000006812
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。